Medical devices, healthcare technology and the business of care
PMA approval · P840001

ITREL(R) TOTALLY IMPLANTABLE SPINAL CORD STIM. SYS

Medtronic Neuromodulation · Decision date Nov 30, 1984

FDA DECISIONP840001

What did the FDA approve?

FDA records P840001 as an original PMA application. The recorded decision is approval, dated Nov 30, 1984.

An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.

Regulatory pathway
Original PMA
Clinical specialty
Neurology
Decision date
Nov 30, 1984

FDA source record

Regulatory record facts

Identifier
P840001
Regulatory pathway
Premarket approval application
Product code
LGW
Decision code
APPR
Decision date
Nov 30, 1984
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.

Product code
LGW
FDA device class
3

FDA decision timeline

  1. P840001 received

    Application receipt date recorded by FDA.

  2. P840001 · FDA decision

    APPR

  3. P840001/S634 · Related supplement

    Vantawith AdaptiveStim Technology - Model 977006

  4. P840001/S632 · Related supplement

    Master Vanta with Restore, Itrel, Synergy, Intellis, AdaptiveStim Vanta and Inceptiv TM Spinal Cord Implantable S

  5. P840001/S635 · Related supplement

    Master Restore, Itrel, Synergy Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces, Specify,

  6. P840001/S636 · Related supplement

    Restore, Itrel, Synergy, Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces-Quad, Specify,

Timeline entries are records held by MedtechLedger for P840001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P840001

Explore the linked device profile

Other records with product code LGW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Neuromodulation

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records